Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-16-016310
Filing Date
2016-12-30
Accepted
2016-12-30 14:33:56
Documents
1
Effectiveness Date
2016-12-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11399
  Complete submission text file 0001493152-16-016310.txt   12748
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-277423 | Film No.: 162077411
SIC: 2834 Pharmaceutical Preparations